This document is an excerpt from the EUR-Lex website
Document 62019TN0697
Case T-697/19: Action brought on 14 October 2019 – Teva Pharmaceutical Industries v EUIPO (Weniger Migräne. Mehr vom Leben)
Case T-697/19: Action brought on 14 October 2019 – Teva Pharmaceutical Industries v EUIPO (Weniger Migräne. Mehr vom Leben)
Case T-697/19: Action brought on 14 October 2019 – Teva Pharmaceutical Industries v EUIPO (Weniger Migräne. Mehr vom Leben)
OJ C 413, 9.12.2019, p. 61–61
(BG, ES, CS, DA, DE, ET, EL, EN, FR, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
|
9.12.2019 |
EN |
Official Journal of the European Union |
C 413/61 |
Action brought on 14 October 2019 – Teva Pharmaceutical Industries v EUIPO (Weniger Migräne. Mehr vom Leben)
(Case T-697/19)
(2019/C 413/73)
Language of the case: English
Parties
Applicant: Teva Pharmaceutical Industries Ltd (Jerusalem, Israel) (represented by: J. Bogatz and Y. Stone, lawyers)
Defendant: European Union Intellectual Property Office (EUIPO)
Details of the proceedings before EUIPO
Trade mark at issue: Application for European Union word mark Weniger Migräne. Mehr vom Leben – Application for registration No 17 942 400
Contested decision: Decision of the Fifth Board of Appeal of EUIPO of 12 August 2019 in Case R 779/2019-5
Form of order sought
The applicant claims that the Court should:
|
— |
annul the contested decision; |
|
— |
order EUIPO to pay the costs incurred by the applicant. |
Plea in law
Infringement of Article 7(1)(b) of Regulation (EU) 2017/1001 of the European Parliament and of the Council.